Investigational New Drugs

Journal Abbreviation: INVEST NEW DRUG
Journal ISSN: 0167-6997

About Investigational New Drugs

    The development of new anticancer agents is one of the most rapidly changing aspects of cancer research. Investigational New Drugs provides a forum for the rapid dissemination of information on new anticancer agents. The papers published are of interest to the medical chemist, toxicologist, pharmacist, pharmacologist, biostatistician and clinical oncologist. Investigational New Drugs provides the fastest possible publication of new discoveries and results for the whole community of scientists developing anticancer agents.<br/><br/>Each issue contains original articles dealing with anticancer drug development. Other sections are devoted to invited review articles and letters to the editor.
Year Impact Factor (IF) Total Articles Total Cites
2022 (2023 update) 3.4 - 5844
2021 3.651 - 6335
2020 3.850 259 5827
2019 3.525 137 4549
2018 2.663 130 3911
2017 3.502 93 4450
2016 3.484 88 4097
2015 3.281 139 3820
2014 2.919 144 3530
2013 2.927 180 3180
2012 3.498 278 2888
2011 3.357 176 2187
2010 3.007 111 1908